Disclosures for "NF2-Related Schwannomatosis Presenting with Multifocal Ependymoma "
-
Mrs. Mathis has nothing to disclose.
-
Dr. Breen has nothing to disclose.
-
Dr. Clarke has nothing to disclose.
-
Jorge Trejo-Lopez has nothing to disclose.
-
Dr. babovic-vuksanovic has received personal compensation in the range of $500-$4,999 for serving as a Consultant for AstraZeneca/Alexion. Dr. babovic-vuksanovic has received personal compensation in the range of $500-$4,999 for serving as a Consultant for SpringWorks. Dr. babovic-vuksanovic has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Alexion. The institution of Dr. babovic-vuksanovic has received research support from SprinWorks. Dr. babovic-vuksanovic has received publishing royalties from a publication relating to health care. Dr. babovic-vuksanovic has received personal compensation in the range of $500-$4,999 for serving as a USMLE items review with NBME.
-
Dr. Kaufmann has stock in SpineThera.
-
Dr. Sener has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Servier Pharmaceuticals. Dr. Sener has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Merck. Dr. Sener has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Alexion.